COVID-19 disruption of clinical trials is likely to result in missing data, disrupted timelines, and perhaps patient population changes. We thought we would dedicate a blog post to the actions... read more →
In this blog we will discuss a particular type of clinical trial design, the non-inferiority trial. We will explain the difference between non-inferiority trials and more typical clinical trial... read more →
What do ISS and ISE mean? ISS and ISE stand for integrated summary of safety and integrated summary of effectiveness, respectively. These are not merely summaries, as the name might... read more →
Introduction In the previous clinical blog, ‘An Introduction to Survival Analysis for Clinical Trials’, I touched on some of the characteristics of survival... read more →
In our last blog we discussed Handling Missing Data in Clinical Trials, and mentioned a kind of missing data known as ‘censoring’. In this blog we focus on techniques for... read more →